• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿尔茨海默病中的微生物群-肠-脑轴与Toll样受体

Microbiota-gut-brain axis and toll-like receptors in Alzheimer's disease.

作者信息

Lin Caixiu, Zhao Shuai, Zhu Yueli, Fan Ziqi, Wang Jing, Zhang Baorong, Chen Yanxing

机构信息

Department of Neurology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.

Department of Neurology, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, Hangzhou, China.

出版信息

Comput Struct Biotechnol J. 2019 Oct 24;17:1309-1317. doi: 10.1016/j.csbj.2019.09.008. eCollection 2019.

DOI:10.1016/j.csbj.2019.09.008
PMID:31921396
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6944716/
Abstract

Alzheimer's disease (AD) is a multifactorial disease which involves both the periphery and central nervous system (CNS). It has been recently recognized that gut microbiota interacts with the gut and brain (microbiota-gut-brain axis), contributing to the pathogenesis of neurodegenerative diseases, such as AD. Dysbiosis of gut microbiota can induce increased intestinal permeability and systemic inflammation, which may lead to the development of AD pathologies and cognitive impairment via the neural, immune, endocrine, and metabolic pathways. Toll-like receptors (TLRs) play an important role in the innate immune system via recognizing microbes-derived pathogens and initiating the inflammatory process. TLRs have also been found in the brain, especially in the microglia, and have been indicated in the development of AD. In this review, we summarized the relationship between microbiota-gut-brain axis and AD, as well as the complex role of TLRs in AD. Intervention of the gut microbiota or modulation of TLRs properly might emerge as promising preventive and therapeutic strategies for AD.

摘要

阿尔茨海默病(AD)是一种涉及外周和中枢神经系统(CNS)的多因素疾病。最近人们认识到,肠道微生物群与肠道和大脑相互作用(微生物群-肠道-脑轴),促进了神经退行性疾病如AD的发病机制。肠道微生物群的失调可导致肠道通透性增加和全身炎症,这可能通过神经、免疫、内分泌和代谢途径导致AD病理改变和认知障碍。Toll样受体(TLRs)通过识别微生物衍生的病原体并启动炎症过程,在先天免疫系统中发挥重要作用。TLRs也在大脑中被发现,尤其是在小胶质细胞中,并且已被证明与AD的发展有关。在这篇综述中,我们总结了微生物群-肠道-脑轴与AD之间的关系,以及TLRs在AD中的复杂作用。适当干预肠道微生物群或调节TLRs可能成为AD有前景的预防和治疗策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/723f/6944716/ff143aa8d1cd/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/723f/6944716/ff143aa8d1cd/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/723f/6944716/ff143aa8d1cd/gr1.jpg

相似文献

1
Microbiota-gut-brain axis and toll-like receptors in Alzheimer's disease.阿尔茨海默病中的微生物群-肠-脑轴与Toll样受体
Comput Struct Biotechnol J. 2019 Oct 24;17:1309-1317. doi: 10.1016/j.csbj.2019.09.008. eCollection 2019.
2
Emerging role of gut microbiota in modulation of neuroinflammation and neurodegeneration with emphasis on Alzheimer's disease.肠道微生物群在神经炎症和神经退行性变中的调节作用的新出现,重点是阿尔茨海默病。
Prog Neuropsychopharmacol Biol Psychiatry. 2021 Mar 2;106:110112. doi: 10.1016/j.pnpbp.2020.110112. Epub 2020 Sep 16.
3
Microbiome-Gut-Brain Axis and Toll-Like Receptors in Parkinson's Disease.肠道微生物群-脑-肠轴与帕金森病中的 Toll 样受体
Int J Mol Sci. 2018 Jun 6;19(6):1689. doi: 10.3390/ijms19061689.
4
Role of gut-brain axis, gut microbial composition, and probiotic intervention in Alzheimer's disease.肠道-大脑轴、肠道微生物组成和益生菌干预在阿尔茨海默病中的作用。
Life Sci. 2021 Jan 1;264:118627. doi: 10.1016/j.lfs.2020.118627. Epub 2020 Oct 22.
5
Interlink between the gut microbiota and inflammation in the context of oxidative stress in Alzheimer's disease progression.肠道微生物群与氧化应激背景下阿尔茨海默病进展中的炎症之间的相互联系。
Gut Microbes. 2023 Jan-Dec;15(1):2206504. doi: 10.1080/19490976.2023.2206504.
6
The Gut Microbiota and Alzheimer's Disease.肠道微生物群与阿尔茨海默病
J Alzheimers Dis. 2017;58(1):1-15. doi: 10.3233/JAD-161141.
7
Brain-Gut-Microbiota Axis in Alzheimer's Disease.阿尔茨海默病中的脑-肠-微生物群轴
J Neurogastroenterol Motil. 2019 Jan 31;25(1):48-60. doi: 10.5056/jnm18087.
8
Gut Microbiota and Dysbiosis in Alzheimer's Disease: Implications for Pathogenesis and Treatment.阿尔茨海默病中的肠道微生物群与生态失调:对发病机制和治疗的影响
Mol Neurobiol. 2020 Dec;57(12):5026-5043. doi: 10.1007/s12035-020-02073-3. Epub 2020 Aug 23.
9
Functional roles of the microbiota-gut-brain axis in Alzheimer's disease: Implications of gut microbiota-targeted therapy.微生物群-肠-脑轴在阿尔茨海默病中的功能作用:肠道微生物群靶向治疗的意义
Transl Neurosci. 2021 Dec 28;12(1):581-600. doi: 10.1515/tnsci-2020-0206. eCollection 2021 Jan 1.
10
Target Dysbiosis of Gut Microbes as a Future Therapeutic Manipulation in Alzheimer's Disease.肠道微生物的靶向失调作为阿尔茨海默病未来的治疗手段
Front Aging Neurosci. 2020 Oct 6;12:544235. doi: 10.3389/fnagi.2020.544235. eCollection 2020.

引用本文的文献

1
Gut dysbiosis as a potential driver of Parkinson's and Alzheimer's disease pathogenesis.肠道微生物群失调作为帕金森病和阿尔茨海默病发病机制的潜在驱动因素。
Front Neurosci. 2025 Aug 13;19:1600148. doi: 10.3389/fnins.2025.1600148. eCollection 2025.
2
Gut Microbiota and White Matter Integrity: A Two-Sample Mendelian Randomization Analysis.肠道微生物群与白质完整性:一项两样本孟德尔随机化分析。
eNeuro. 2025 Sep 4;12(9). doi: 10.1523/ENEURO.0586-24.2025. Print 2025 Sep.
3
Komagataella pastoris KM71H Attenuates Cognitive Deficits and Depressive-Like Behavior by the TLR4/NF-κB Signaling Pathway in an Aβ-Induced AD-Like Mouse Model.

本文引用的文献

1
Sodium oligomannate therapeutically remodels gut microbiota and suppresses gut bacterial amino acids-shaped neuroinflammation to inhibit Alzheimer's disease progression.低聚甘露糖通过治疗重塑肠道微生物群,抑制肠道细菌氨基酸诱导的神经炎症来抑制阿尔茨海默病的进展。
Cell Res. 2019 Oct;29(10):787-803. doi: 10.1038/s41422-019-0216-x. Epub 2019 Sep 6.
2
Mild cognitive impairment has similar alterations as Alzheimer's disease in gut microbiota.轻度认知障碍的肠道微生物群与阿尔茨海默病有相似的改变。
Alzheimers Dement. 2019 Oct;15(10):1357-1366. doi: 10.1016/j.jalz.2019.07.002. Epub 2019 Aug 18.
3
Tau immunotherapies for Alzheimer's disease.
在Aβ诱导的类阿尔茨海默病小鼠模型中,毕赤酵母KM71H通过TLR4/NF-κB信号通路减轻认知缺陷和类抑郁行为。
Mol Neurobiol. 2025 Aug 6. doi: 10.1007/s12035-025-05267-9.
4
Bridging the brain and gut: neuroimmune mechanisms of neuroinflammation and therapeutic insights.连接大脑与肠道:神经炎症的神经免疫机制及治疗见解
Front Cell Neurosci. 2025 Jun 13;19:1590002. doi: 10.3389/fncel.2025.1590002. eCollection 2025.
5
Microbiome Engineering for Biotherapeutic in Alzheimer's Disease Through the Gut-Brain Axis: Potentials and Limitations.通过肠-脑轴进行阿尔茨海默病生物治疗的微生物组工程:潜力与局限
Int J Mol Sci. 2025 Jun 2;26(11):5351. doi: 10.3390/ijms26115351.
6
Resilience and charge-dependent fibrillation of functional amyloid: Interactions of Pseudomonas biofilm-associated FapB and FapC amyloids.功能性淀粉样蛋白的弹性和电荷依赖性原纤维形成:铜绿假单胞菌生物膜相关FapB和FapC淀粉样蛋白的相互作用
J Biol Chem. 2025 Feb;301(2):108096. doi: 10.1016/j.jbc.2024.108096. Epub 2024 Dec 18.
7
Herbal medicines in Alzheimer's disease and the involvement of gut microbiota.用于治疗阿尔茨海默病的草药及肠道微生物群的作用
Front Pharmacol. 2024 Jul 16;15:1416502. doi: 10.3389/fphar.2024.1416502. eCollection 2024.
8
Necrotizing Enterocolitis and the Preterm Infant Microbiome.新生儿坏死性小肠结肠炎与早产儿肠道微生物组
Adv Exp Med Biol. 2024;1449:29-41. doi: 10.1007/978-3-031-58572-2_2.
9
Cognitive impairment and the gut-brain axis during 2014-2023: a bibliometric analysis.2014 - 2023年期间的认知障碍与肠脑轴:一项文献计量分析
Front Neurol. 2024 Jul 5;15:1407956. doi: 10.3389/fneur.2024.1407956. eCollection 2024.
10
A Review on the Protective Effects of Probiotics against Alzheimer's Disease.益生菌对阿尔茨海默病保护作用的综述
Biology (Basel). 2023 Dec 22;13(1):8. doi: 10.3390/biology13010008.
用于治疗阿尔茨海默病的 Tau 免疫疗法。
Expert Opin Investig Drugs. 2019 Jun;28(6):545-554. doi: 10.1080/13543784.2019.1619694. Epub 2019 May 22.
4
Extensive Unexplored Human Microbiome Diversity Revealed by Over 150,000 Genomes from Metagenomes Spanning Age, Geography, and Lifestyle.从来自不同年龄、地理和生活方式的宏基因组中超过 15 万条基因组揭示了广泛未被探索的人类微生物组多样性。
Cell. 2019 Jan 24;176(3):649-662.e20. doi: 10.1016/j.cell.2019.01.001. Epub 2019 Jan 17.
5
Probiotic and selenium co-supplementation, and the effects on clinical, metabolic and genetic status in Alzheimer's disease: A randomized, double-blind, controlled trial.益生菌和硒联合补充对阿尔茨海默病患者临床、代谢和遗传状况的影响:一项随机、双盲、对照试验。
Clin Nutr. 2019 Dec;38(6):2569-2575. doi: 10.1016/j.clnu.2018.11.034. Epub 2018 Dec 10.
6
The antimicrobial protection hypothesis of Alzheimer's disease.阿尔茨海默病的抗菌保护假说。
Alzheimers Dement. 2018 Dec;14(12):1602-1614. doi: 10.1016/j.jalz.2018.06.3040. Epub 2018 Oct 9.
7
Amyloid positron emission tomography and cerebrospinal fluid results from a crenezumab anti-amyloid-beta antibody double-blind, placebo-controlled, randomized phase II study in mild-to-moderate Alzheimer's disease (BLAZE).淀粉样蛋白正电子发射断层扫描和脑脊液结果来自 crenezumab 抗淀粉样蛋白-β 抗体在轻度至中度阿尔茨海默病(BLAZE)的双盲、安慰剂对照、随机 2 期研究。
Alzheimers Res Ther. 2018 Sep 19;10(1):96. doi: 10.1186/s13195-018-0424-5.
8
Alzheimer's Disease-Associated β-Amyloid Is Rapidly Seeded by Herpesviridae to Protect against Brain Infection.阿尔茨海默病相关β-淀粉样蛋白被疱疹病毒家族快速引发以抵御脑部感染。
Neuron. 2018 Jul 11;99(1):56-63.e3. doi: 10.1016/j.neuron.2018.06.030.
9
The Claudin-like Protein HPO-30 Is Required to Maintain LAChRs at the Neuromuscular Junction.Claudin 样蛋白 HPO-30 对于维持神经肌肉接头处的 LAChRs 是必需的。
J Neurosci. 2018 Aug 8;38(32):7072-7087. doi: 10.1523/JNEUROSCI.3487-17.2018. Epub 2018 Jun 27.
10
Impact of gut microbiota on neurological diseases: Diet composition and novel treatments.肠道微生物群对神经疾病的影响:饮食成分和新疗法。
Crit Rev Food Sci Nutr. 2019;59(19):3102-3116. doi: 10.1080/10408398.2018.1484340. Epub 2018 Jul 12.